TABLE 1.
Cytotoxic response to Gag and Env in the immunized animals
ALVAC-SIV-gpe (vcp180) vacci-nation routea | gp120 boostb | Animal no.c | % percent CTL activityb at week:
|
|||||
---|---|---|---|---|---|---|---|---|
28
|
54
|
115
|
||||||
Env | Gag | Env | Gag | Env | Gag | |||
IM | − | 428 | 10 | —e | 9 | — | 32 | — |
IM | − | 398 | 12 | — | 16 | — | — | — |
IM | − | 411 | 11 | — | — | — | 28 | — |
IM | − | 412 | — | — | — | — | 25 | — |
IM | − | 397 | — | — | — | — | — | — |
IM | − | 423 | — | — | — | — | — | |
IM | + | 402 | 22 | — | 40 | — | 42 | 26 |
IM | + | 401 | 10 | — | 12 | — | 32 | — |
IM | + | 416 | 12 | — | 23 | — | 14 | — |
IM | + | 415 | 17 | — | 22 | — | — | — |
IM | + | 429 | 13 | — | — | — | — | 26 |
IM | + | 414 | 18 | — | — | — | — | — |
IM, IR, IN | − | 400 | 17 | — | 47 | — | 28 | — |
IM, IR, IN | − | 410 | 10 | — | — | — | — | — |
IM, IR, IN | − | 399 | — | — | — | — | — | — |
IM, IR, IN | − | 413 | — | — | — | — | — | — |
IM, IR, IN | − | 424 | — | — | — | — | — | — |
IM, IR, IN | − | 435 | — | — | — | — | — | — |
IM, IR, IN | + | 409 | 22 | — | — | — | 33 | — |
IM, IR, IN | + | 417 | 10 | — | — | — | — | — |
IM, IR, IN | + | 418 | — | — | — | — | 19 | — |
IM, IR, IN | + | 430 | NDf | ND | 11 | — | — | — |
IM, IR, IN | + | 403 | — | — | — | — | — | — |
IM, IR, IN | + | 404 | — | — | — | — | — | — |
IM, intramuscular; IR, intrarectal; IN, intranasal.
gp120 was given intramuscularly in QS-21 adjuvant.
Boldfaced numbers, Mamu-A*01-positive animals.
Percentage of cytolytic activity at an effector-to-target ratio of 20:1; cumulative CTL response: 16 of 24 (67%).
—, no cytotoxic activity.
ND, not determined.